These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 32419626)

  • 1. Non-walled spherical
    Zou J; Kou SH; Xie R; VanNieuwenhze MS; Qu J; Peng B; Zheng J
    Emerg Microbes Infect; 2020 Dec; 9(1):1149-1159. PubMed ID: 32419626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial Activity of Gallium Protoporphyrin IX against Acinetobacter baumannii Strains Displaying Different Antibiotic Resistance Phenotypes.
    Arivett BA; Fiester SE; Ohneck EJ; Penwell WF; Kaufman CM; Relich RF; Actis LA
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7657-65. PubMed ID: 26416873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eradication of persister cells of Acinetobacter baumannii through combination of colistin and amikacin antibiotics.
    Chung ES; Ko KS
    J Antimicrob Chemother; 2019 May; 74(5):1277-1283. PubMed ID: 30759206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of persisters influenced by aeration in Acinetobacter calcoaceticus-baumannii.
    Donamore BK; Gallo SW; Abreu Ferreira PM; Sanchez Ferreira CA; de Oliveira SD
    Future Microbiol; 2018 Feb; 13():209-219. PubMed ID: 29302999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous persister cells formation in Acinetobacter baumannii.
    Barth VC; Rodrigues BÁ; Bonatto GD; Gallo SW; Pagnussatti VE; Ferreira CA; de Oliveira SD
    PLoS One; 2013; 8(12):e84361. PubMed ID: 24391945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent β-Lactam Enhancer Activity of Zidebactam and WCK 5153 against Acinetobacter baumannii, Including Carbapenemase-Producing Clinical Isolates.
    Moya B; Barcelo IM; Bhagwat S; Patel M; Bou G; Papp-Wallace KM; Bonomo RA; Oliver A
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A New Class of Cell Wall-Recycling l,d-Carboxypeptidase Determines β-Lactam Susceptibility and Morphogenesis in Acinetobacter baumannii.
    Dai Y; Pinedo V; Tang AY; Cava F; Geisinger E
    mBio; 2021 Dec; 12(6):e0278621. PubMed ID: 34872350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-persister activity of squalamine against Acinetobacter baumannii.
    Nicol M; Mlouka MAB; Berthe T; Di Martino P; Jouenne T; Brunel JM; Dé E
    Int J Antimicrob Agents; 2019 Mar; 53(3):337-342. PubMed ID: 30423343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of epigallocatechin-3-gallate (EGCG) and its synergism with β-lactam antibiotics sensitizing carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii.
    Lee S; Razqan GS; Kwon DH
    Phytomedicine; 2017 Jan; 24():49-55. PubMed ID: 28160861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing the anticancer drug mitomycin C for the treatment of persistent Acinetobacter baumannii infections.
    Cruz-Muñiz MY; López-Jacome LE; Hernández-Durán M; Franco-Cendejas R; Licona-Limón P; Ramos-Balderas JL; Martinéz-Vázquez M; Belmont-Díaz JA; Wood TK; García-Contreras R
    Int J Antimicrob Agents; 2017 Jan; 49(1):88-92. PubMed ID: 27939675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas syringae pv.
    Patel RR; Kandel PP; Traverso E; Hockett KL; Triplett LR
    mBio; 2021 Apr; 12(2):. PubMed ID: 33849974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Mechanisms of Antimicrobial Resistance of Acinetobacter baumannii.
    Esterly JS; Richardson CL; Eltoukhy NS; Qi C; Scheetz MH
    Ann Pharmacother; 2011 Feb; 45(2):218-28. PubMed ID: 21304033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and Transcriptome Analysis of Acinetobacter baumannii Persister Cells.
    Alkasir R; Ma Y; Liu F; Li J; Lv N; Xue Y; Hu Y; Zhu B
    Microb Drug Resist; 2018 Dec; 24(10):1466-1474. PubMed ID: 29902105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activities of various beta-lactams and beta-lactam/beta-lactamase inhibitor combinations against Acinetobacter baumannii and Acinetobacter DNA group 3 strains.
    Brauers J; Frank U; Kresken M; Rodloff AC; Seifert H
    Clin Microbiol Infect; 2005 Jan; 11(1):24-30. PubMed ID: 15649300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the Development of Persisters in Extensively Drug-Resistant Acinetobacter baumannii upon Exposure to Polymyxin B-Based Antibiotic Combinations Using Flow Cytometry.
    Wong FH; Cai Y; Leck H; Lim TP; Teo JQ; Lee W; Koh TH; Tan TT; Tan KW; Kwa AL
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31818819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased ompW and ompA expression and higher virulence of Acinetobacter baumannii persister cells.
    Schmitt BL; Leal BF; Leyser M; de Barros MP; Trentin DS; Ferreira CAS; de Oliveira SD
    BMC Microbiol; 2023 May; 23(1):157. PubMed ID: 37246220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humanized Exposures of a β-Lactam-β-Lactamase Inhibitor, Tazobactam, versus Non-β-Lactam-β-Lactamase Inhibitor, Avibactam, with or without Colistin, against Acinetobacter baumannii in Murine Thigh and Lung Infection Models.
    Monogue ML; Sakoulas G; Nizet V; Nicolau DP
    Pharmacology; 2018; 101(5-6):255-261. PubMed ID: 29533955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Inactivation of d,d-Transpeptidases of Acinetobacter baumannii on Bacterial Growth and Susceptibility to β-Lactam Antibiotics.
    Toth M; Lee M; Stewart NK; Vakulenko SB
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0172921. PubMed ID: 34780270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril!
    Thomson JM; Bonomo RA
    Curr Opin Microbiol; 2005 Oct; 8(5):518-24. PubMed ID: 16126451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctive attributes of β-lactam target proteins in Acinetobacter baumannii relevant to development of new antibiotics.
    Han S; Caspers N; Zaniewski RP; Lacey BM; Tomaras AP; Feng X; Geoghegan KF; Shanmugasundaram V
    J Am Chem Soc; 2011 Dec; 133(50):20536-45. PubMed ID: 22050378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.